MC

Michael Chambers

North America, North Dakota, United States, Fargo

Description

Michael Chambers is the Co-Founder at Agathos Biologics.Michael’s vision and leadership of Aldevron has resulted in several milestones inclu...

Investor Profile

Michael Chambers has made 3 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series A (67%)
  • Series Unknown (33%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Genetics
  • Life Science
  • Health Care
  • Biopharma
  • Pharmaceutical
  • Education
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Michael Chambers frequently co-invest with?

The Engine
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
Alix Ventures
North America, California, United States, San Francisco
Co-Investments: 1
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 1
Northpond Ventures
North America, Maryland, United States, Bethesda
Co-Investments: 2
Horizon Ventures
North America, California, United States, Los Altos
Co-Investments: 1
BoxGroup
North America, New York, United States, New York
Co-Investments: 1
Selvedge Venture
Europe, England, United Kingdom, London
Co-Investments: 1
Fifty Years
North America, California, United States, San Francisco
Co-Investments: 1
TBD Angels
North America, Massachusetts, United States, Boston
Co-Investments: 1
MassVentures
North America, Massachusetts, United States, Boston
Co-Investments: 1

Which angels does Michael Chambers often collaborate with?

CG
North America, Utah, United States, Salt Lake City
Shared Deals: 1
MD
North America, Massachusetts, United States, Hyannis
Shared Deals: 1
MA
North America, California, United States, San Francisco
Shared Deals: 1
JB
North America, North Dakota, United States, Fargo
Shared Deals: 1

What are some of recent deals done by Michael Chambers?

64x Bio

San Francisco, California, United States

64x Bio builds a platform that increases the speed and scale of mammalian cell line discovery.

BiopharmaBiotechnologyGeneticsLife SciencePharmaceutical
Series AJan 19, 2022
Amount Raised: $55,000,000
Kytopen

Cambridge, Massachusetts, United States

Kytopen developer of a cell therapy platform for non-viral delivery of molecules into hard-to-transfect immune cells.

BiotechnologyGeneticsHealth CareLife Science
Series ASep 28, 2021
Amount Raised: $30,000,000
Erbi Biosystems

Woburn, Massachusetts, United States

Erbi Biosystems is a transformative microfluidic bioprocess instrumentation company.

BiotechnologyEducation
Series UnknownJan 4, 2021